Abbott's Libre 2 iCGM Gets FDA Nod to Better Manage Diabetes
Zacks via Yahoo Finance· 10 months agoNotably, the system is the most durable self-applied iCGM sensor currently available in the market...
Abbott to hike production of lower-cost glucose monitors as diabetes soars
Reuters via Yahoo News· 2 years agoAbbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose...
I Tested CGM, the Hottest New Tool in Biohacking. Here's What Happened.
Men's Health via Yahoo News· 1 month agoThe needle—more like a filament, actually—is attached to a sensor called a continuous glucose...
CGM Devices Gain Steam, Set New Trend in Diabetes Management
Zacks via Yahoo Finance· 2 years agoAbbott Laboratories ABT, a Zacks Rank #3 (Hold) stock, has partnered with biopharmaceutical major,...
Is Abbott Labs a Good Stock to Buy Now?
Motley Fool· 2 months agoLive video recorded on Jan. 29, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Cory Renauer discuss Abbott Labs' successful line of constant glucose monitors (